Suppr超能文献

用于 mRNA 递送的纳米颗粒表征的分析技术。

Analytical techniques for the characterization of nanoparticles for mRNA delivery.

机构信息

Merck KGaA, Darmstadt, Germany.

Merck KGaA, Darmstadt, Germany.

出版信息

Eur J Pharm Biopharm. 2024 May;198:114235. doi: 10.1016/j.ejpb.2024.114235. Epub 2024 Feb 23.

Abstract

Nanotechnology-assisted RNA delivery has gotten a tremendous boost over the last decade and made a significant impact in the development of life-changing vaccines and therapeutics. With increasing numbers of emerging lipid- and polymer-based RNA nanoparticles progressing towards the clinic, it has become apparent that the safety and efficacy of these medications depend on the comprehensive understanding of their critical quality attributes (CQAs). However, despite the rapid advancements in the field, the identification and reliable quantification of CQAs remain a significant challenge. To support these efforts, this review aims to summarize the present knowledge on CQAs based on the regulatory guidelines and to provide insights into the available analytical characterization techniques for RNA-loaded nanoparticles. In this context, routine and emerging analytical techniques are categorized and discussed, focusing on the operation principle, strengths, and potential limitations. Furthermore, the importance of complementary and orthogonal techniques for the measurement of CQAs is discussed in order to ensure the quality and consistency of analytical methods used, and address potential technique-based differences.

摘要

在过去的十年中,纳米技术辅助的 RNA 递呈得到了极大的推动,并在改变生活的疫苗和疗法的开发中产生了重大影响。随着越来越多新兴的基于脂质和聚合物的 RNA 纳米颗粒进入临床阶段,很明显这些药物的安全性和疗效取决于对其关键质量属性(CQAs)的全面理解。然而,尽管该领域取得了快速进展,但 CQAs 的识别和可靠定量仍然是一个重大挑战。为了支持这些努力,本综述旨在根据监管指南总结关于 CQAs 的现有知识,并深入了解用于负载 RNA 的纳米颗粒的现有分析特性鉴定技术。在这方面,对常规和新兴的分析技术进行了分类和讨论,重点关注操作原理、优势和潜在局限性。此外,还讨论了互补和正交技术在 CQAs 测量中的重要性,以确保所使用分析方法的质量和一致性,并解决潜在的基于技术的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验